How have MMEDF shares performed in 2024?

Mind Medicine (MindMed)'s stock was trading at $3.66 at the beginning of the year. Since then, MMEDF shares have increased by 143.4% and is now trading at $8.91. View the best growth stocks for 2024 here .

How do I buy shares of Mind Medicine (MindMed)?

Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MMEDF

Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Free MMEDF Stock Alerts

$8.91

-0.62 (-6.51%)

(As of 04/18/2024 ET)

Compare

Today's Range: $8.85
▼
$9.66
50-Day Range: $4.38
▼
$11.75
52-Week Range: $0.29
▼
$5.07

Volume: 1.65 million shs
Average Volume: 3.38 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines

Get Mind Medicine (MindMed) alerts:

Ad Darwin

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

[Get Your Insights Now]

About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

MMEDF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MMEDF Stock News Headlines

April 17, 2024 | finance.yahoo.com

Mind Medicine (MindMed) Inc. (MNMD)

March 27, 2024 | msn.com

Mind Medicine (NASDAQ:MNMD) is Leading the Surge in Psychedelic Therapies

April 18, 2024 | DTI (Ad)

Start loving Mondays like this

Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!

March 22, 2024 | morningstar.com

Mind Medicine Inc Ordinary Shares

March 17, 2024 | morningstar.com

Mind Medicine Inc Ordinary Shares MMED

February 22, 2024 | benzinga.com

Mind Medicine Stock (NASDAQ:MNMD) Dividends: History, Yield and Dates

December 20, 2023 | seekingalpha.com

MMDCF Mind Medicine (MindMed) Inc. WT EXP 010724

December 20, 2023 | msn.com

What Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy Stock

April 18, 2024 | DTI (Ad)

Start loving Mondays like this

December 12, 2023 | finance.yahoo.com

Mind Medicine (MindMed) Inc. (MMCWF)

October 26, 2023 | financialpost.com

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update

August 15, 2023 | benzinga.com

MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year

August 4, 2023 | msn.com

RBC Capital Maintains Mind Medicine (MNMD) Outperform Recommendation

July 19, 2023 | stockhouse.com

Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?

July 4, 2023 | thestreet.com

Mind Medicine (MindMed), Inc.

June 27, 2023 | msn.com

MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld

June 22, 2023 | marketwatch.com

8-K: Mind Medicine (MindMed) Inc.

May 25, 2023 | businesswire.com

MindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and Shareholders

May 5, 2023 | benzinga.com

FCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management's Track Record of Shareholder Value Destruction

May 1, 2023 | benzinga.com

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update

April 26, 2023 | msn.com

MindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital Management

November 11, 2022 | benzinga.com

MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials

October 26, 2022 | msn.com

Mind Medicine (MNMD) to Report Q3 Earnings: What's in Store?

October 4, 2022 | nasdaq.com

Why Mind Medicine Stock Triumphed on Tuesday

September 29, 2022 | nasdaq.com

Why Mind Medicine Stock Soared on a Down Day for the Market

September 29, 2022 | uk.investing.com

Mind Medicine Inc (MNMD)

September 28, 2022 | nasdaq.com

Mind Medicine Stock (NASDAQ:MNMD): Investors Just Got a Dose of Reality

See More Headlines

Receive MMEDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:MMEDF
CUSIP: N/A
CIK: N/A
Web: www.mindmed.co
Phone: N/A
Fax: N/A
Employees: 22
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Jamon Alexander Rahn
Co-Founder, CEO & Director
Dr. Miriam Halperin Wernli
Exec. Pres & Director
Dr. Scott M. Freeman (Age 64)
Co-Founder & Clinical Advisor
Mr. Leonard Latchman
Co-founder
Mr. David Dean Guebert
Chief Financial Officer
Ms. Carol Nast
Chief Operating Officer
Mr. Bradford Cross
Chief Technology Officer
Dr. Donald R. Gehlert Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
Ms. Madeline Feldman
Director of Operations & Admin.
Mr. Collin Gage
VP of Corp. Devel.

Key Competitors

View All Competitors

MMEDF Stock Analysis - Frequently Asked Questions

How have MMEDF shares performed in 2024?: Mind Medicine (MindMed)'s stock was trading at $3.66 at the beginning of the year. Since then, MMEDF shares have increased by 143.4% and is now trading at $8.91.
View the best growth stocks for 2024 here.
How do I buy shares of Mind Medicine (MindMed)?: Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MMEDF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial